Cryptococcus neoformans (Sanfelice) Vuillemin-质粒载体-ATCC-DSM-CCUG-泰斯拓生物

你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: 0574-87917803
Cryptococcus neoformans (Sanfelice) Vuillemin
Cryptococcus neoformans (Sanfelice) Vuillemin
规格:
货期:
编号:TS146555
品牌:Testobio
产品名称: Cryptococcus neoformans (Sanfelice) Vuillemin
商品货号: TS146555
Deposited As: Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph
Strain Designations: C21F2
Alternate State: Filobasidiella neoformans Kwon-Chung
Application:
resistant to tacrolimus FK-506, FK506
sensitive to cyclosporin A S-7481/F-1
sensitive to rapamycin
Emerging infectious disease research
Biomedical Research and Development Material
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: frozen
Type Strain: no
Genotype: MATalpha FKR1-1 RefArndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165
Preceptrol®: no
Mating Type: alpha RefArndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165
Medium: ATCC® Medium 1245: YEPD
Growth Conditions:
Temperature: 25.0°C
Name of Depositor: J Heitman
Special Collection: NCRR Contract
References:

Odom A, et al. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16: 2576-2589, 1997. PubMed: 9184205

Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165

Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165

Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165

首页 > 产品中心 > 微生物培养 > 菌株 > null > Cryptococcus neoformans (Sanfelice) Vuillemin

Cryptococcus neoformans (Sanfelice) Vuillemin

  • 货号: TS146555
  • 好评
有货
  • 品牌 : TESTOBIO
产品名称: Cryptococcus neoformans (Sanfelice) Vuillemin
商品货号: TS146555
Deposited As: Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph
Strain Designations: C21F2
Alternate State: Filobasidiella neoformans Kwon-Chung
Application:
resistant to tacrolimus FK-506, FK506
sensitive to cyclosporin A S-7481/F-1
sensitive to rapamycin
Emerging infectious disease research
Biomedical Research and Development Material
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: frozen
Type Strain: no
Genotype: MATalpha FKR1-1 RefArndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165
Preceptrol®: no
Mating Type: alpha RefArndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165
Medium: ATCC® Medium 1245: YEPD
Growth Conditions:
Temperature: 25.0°C
Name of Depositor: J Heitman
Special Collection: NCRR Contract
References:

Odom A, et al. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16: 2576-2589, 1997. PubMed: 9184205

Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165

Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165

Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165

合作单位: